| Authors: |
Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA 02142., Shulman DS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115., DelRocco NJ; Children's Oncology Group, Monrovia, CA 91016.; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90032., Klega K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA 02142., Han R; Children's Oncology Group, Monrovia, CA 91016.; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90032., Krailo MD; Children's Oncology Group, Monrovia, CA 91016.; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA 90032., Slack JC; Robert J. Tomsich Institute of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH 44195., Tanhaemami M; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA 02142., Ward A; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115., Bainer V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115., Ricker C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115., Sparks J; Biopathology Center, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205., Bailey KM; University of Pittsburgh School of Medicine, 4401 Penn Avenue, Pittsburgh, PA 15224., Reed DR; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065., DuBois SG; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115., Leavey P; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390.; Children's Medical Center, Dallas, TX 75235., Mascarenhas L; Cedars-Sinai Medical Center, Los Angeles, CA 90048., Grohar PJ; Department of Pediatrics, Division of Pediatric Hematology Oncology, University of Michigan Medical School, CS Mott Children's Hospital, Ann Arbor, MI 48109., Church AJ; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115., Crompton BD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA 02142., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.; Harvard Medical School, Boston, MA 02115.; Boston Children's Hospital, Boston, MA 02115.; Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA 02142. |
